Webpackaging logo

PharmaPack interviews Dr. Rolf Abelmann, Managing Director of IVM about CRP

Europe, France, Switzerland, France, Germany, Austria, Germany, Health, Pharmaceuticals, OTC (Over the Counter) Drugs, Active, Smart Packaging, Security Measures, Child-Proofing, CP, Laboratory, Testing, Certification, Shows, Associations, Media, Packaging Trade Shows, Events, Pharmapack

Child-resistant packaging, is designed to prevent young children from ingesting products that could be harmful or toxic. CRP is a growing area in packaging with analysts' forecast that expect +7.4% growth over the next 5 years. PharmaPack interviews Dr. Rolf Abelmann, Managing Director of IVM (Institut VerpackungsMarktforschung GmbH) to find out more.

For what kind of drugs are CRP features important?

Child-resistant packages should be used when the packaged pharmaceutical product contains a potential harmful dose for small children. By this children shall be protected of unintentional poisoning.

What markets have regulatory requirements on CRP features? Are they all mandatory?

As an example all drugs on prescription (even mass therapies like calcium channel blocker or SSRIs, beside the well-known therapies in oncology etc.) as well as a list of OTC products (like NSARs) have to be packed child-resistant in the US. This is regulated in the Poison Prevention Packaging Act (PPPA). European countries like Germany, the UK, etc as well as countries like Australia or New Zealand have also published lists of pharmaceutical active ingredients that require CRP.

What are barriers for pharma companies that keep them from adopting CRP features?

Missing awareness of different international legislation for child intoxication data can be a reason. Also misinterpretation of testing and certification legislation can lead to incorrect decisions in pharmaceutical packaging selection. Very often changes in packaging in the pharmaceutical industry also require a very long time.

What advice you can give for pharma to start CRP project now?

The goal of selecting or designing CRP must be defined at the beginning of the development of medicines and its packaging. Only certified CRP products comply with international regulations. To start with a project now is useful, because regarding the regulations to the topic “Serialization”, a change in packaging is ongoing.

Register to attend PharmaPack Europe 2018.

See also

The future is now – Pharmapack Europe 2018 to showcase evolution and revolution in packaging and drug delivery

Pharmapack Europe 2018 (#pharmapackeu) today announced the comprehensive event programme for Europe’s dedicated pharmaceutical packaging and drug delivery conference and exhibition taking place on 7–8 February at Paris Expo Porte de Versailles, Paris. The packed event programme includes key note speeches from leading industry figures, a symposium, educational workshops, and a learning lab that will explore regulatory changes and impacts, challenges in packaging & devices development: biologics, materials, sustainability and quality consistency, and how new patient-centric innovations in drug delivery will revolutionise lives and improve treatment adherence.

  • Interview
  • English
  • Modified 10 Nov 2017
  • Hits 1067